As of December 2024, the FDA approved tirzepatide for treatment of moderate-to-severe obstructive sleep apnea (OSA) in patients with obesity based on the results of two trials
This can be a good way to reduce the amount of colds and viruses you suffer from in the winter months too
Heres how it stacks up against the competition: For a flat, all-in price instead of Ros coaching-and-insurance bundle, see our Peak Wellness vs Ro comparison
Thankfully, Everlywell (like competitor LetsGetChecked), uses its in-house CLIA-certified and CAP-accredited lab to process your samples
Transparent communication about all symptomsmood, physical, and metabolicenables coordinated decision-making
Increase frequency of glucose monitoring with changes to: insulin dosage, concomitantly administered glucose lowering medications, meal pattern, physical activity